Dr. Danielle Citrolo describes mechanisms of action, clinical research, interactions, and future applications for citicoline. She also explains how practitioners may consider using this therapeutic nutrient in clinical practice.
About the Expert
Danielle Citrolo, PharmD, is manager of technical services at Kyowa Hakko, where she provides technical, scientific, and regulatory support. She also acts as liaison with regulatory authorities in the United States, Canada, and Latin America. Before joining Kyowa, Citrolo was the clinical coordinator at The Hospital for Special Surgery in New York City. She has experience in developing clinical research protocols and managing clinical trials. She earned her bachelor of science in biochemistry and bachelor of arts in chemistry from North Carolina State University and her doctorate in pharmacy from Albany College of Pharmacy in New York. She is licensed by the New York State Board of Pharmacy.
About the Sponsor
Kyowa Hakko manufactures Cognizin Citicoline, an ingredient backed by numerous scientific studies to support claims of improved attention, recall, and focus. Often called a “brain nutrient,” citicoline increases levels of several important neurotransmitters, including acetylcholine, dopamine, and noradrenalin, that help maintain the integrity of neuronal cell membranes and increase energy production in the frontal cortex. Because cell membranes have a very high turnover rate, these phospholipids must be continuously synthesized to ensure the adequate function of cells. Cognizin is a pure, vegetarian, allergen-free form of citicoline that provides nutritional support to help combat the normal effects of aging on cognition.
For more information, visit www.cognizin.com.